04/02/2024 3:15 PM | Fisher Andrew (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 7:47 AM | Verona Pharma (Filer)
| Form ARS | |
03/20/2024 7:46 AM | Verona Pharma (Filer)
| Form DEF 14A | |
03/12/2024 6:45 PM | Gupta Rishi (Reporting) Verona Pharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024 3:18 PM | Verona Pharma (Filer)
| Form PRE 14A | |
03/07/2024 8:40 PM | Fisher Andrew (Reporting) Verona Pharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
03/04/2024 7:15 PM | ORBIMED ADVISORS LLC (Reporting) Verona Pharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
02/29/2024 8:00 AM | Verona Pharma (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/29/2024 5:08 AM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/05/2024 5:09 PM | Hahn Mark W (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:10 PM | Poll Claire (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:11 PM | Rickard Kathleen A. (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:11 PM | Verona Pharma (Issuer) ZACCARDELLI DAVID (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 5:02 AM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/02/2024 5:05 AM | Austwick Michael (Reporting) Verona Pharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
02/02/2024 5:07 AM | Austwick Michael (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 5:02 AM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2023 3:15 PM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/22/2023 4:09 PM | Edwards Martin (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2023 3:15 PM | EBSWORTH DAVID R (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 7:08 PM | Hahn Mark W (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 7:09 PM | Verona Pharma (Issuer) ZACCARDELLI DAVID (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 7:09 PM | Poll Claire (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 7:11 PM | Rickard Kathleen A. (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 3:25 PM | Rickard Kathleen A. (Reporting) Verona Pharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023 3:16 PM | Verona Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023 5:24 AM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/24/2023 3:06 PM | Rickard Kathleen A. (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/24/2023 3:06 PM | Verona Pharma (Issuer) ZACCARDELLI DAVID (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2023 5:02 AM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2023 3:05 PM | ACKERMANN CHRISTINA (Reporting) Verona Pharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
09/05/2023 3:05 PM | ACKERMANN CHRISTINA (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2023 8:15 PM | Poll Claire (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2023 8:17 PM | Hahn Mark W (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2023 8:17 PM | Verona Pharma (Issuer) ZACCARDELLI DAVID (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2023 8:19 PM | Rickard Kathleen A. (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/03/2023 7:31 PM | Hahn Mark W (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/03/2023 7:27 PM | Rickard Kathleen A. (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/03/2023 7:29 PM | Verona Pharma (Issuer) ZACCARDELLI DAVID (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/03/2023 7:30 PM | Poll Claire (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/03/2023 3:12 PM | Rickard Kathleen A. (Reporting) Verona Pharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin
Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> |
08/03/2023 7:34 AM | Verona Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/03/2023 5:11 AM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/15/2023 5:06 PM | Gupta Rishi (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2023 5:07 PM | ORBIMED ADVISORS LLC (Reporting) OrbiMed Capital GP VI LLC (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/11/2023 5:18 PM | ORBIMED ADVISORS LLC (Reporting) Verona Pharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2023 7:47 AM | Verona Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/09/2023 5:13 AM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/03/2023 6:46 PM | Verona Pharma (Issuer) ZACCARDELLI DAVID (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2023 6:48 PM | Hahn Mark W (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2023 6:49 PM | Rickard Kathleen A. (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2023 6:49 PM | Poll Claire (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2023 3:38 PM | Rickard Kathleen A. (Reporting) Verona Pharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2023 4:21 PM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/28/2023 3:24 PM | Deschamps Lisa (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |